VWAV

VisionWave is a March-2024-formed defense-AI concept that reached public markets via a reverse acquisition, and the numbers say it is a pre-commercial shell, not a business. FY2025 shows no revenue, a -$6.55M net loss, -$6.74M operating loss, and — most damningly — $0.00 cash against $14.5M of liabilities. Total assets are just $2.69M, so liabilities swamp the entire asset base and stockholders' equity is negative -$11.8M (liabilities/equity of -1.23x is a mathematical artifact of insolvency, not leverage). Operating cash flow of -$2.84M with zero cash on hand means the company cannot fund itself and is wholly dependent on raising new capital; at 16.5M shares any raise is likely dilutive at these depressed prices.

The filing language reinforces the picture rather than softening it. Management concluded internal control over financial reporting was ineffective as of September 30, 2025, citing material weaknesses — inadequate segregation of duties and insufficient written accounting policies for US GAAP/SEC compliance — and admits it is only 'in the early stages' of remediation, still hiring accounting staff and a third-party consultant. That undermines confidence in the very figures being reported. The MD&A confirms the products are prototypes: nine product lines at 'prototype phase,' 'undergoing trials and demonstrations,' with deployment explicitly 'subject to obtaining appropriate financing and large-scale purchase order of which there is no guarantee.' 'Ready for deployment' is defined down to mean technological capability, not inventory or orders. R&D spend of just $156K is far too small to be commercializing radar/RF/autonomous defense systems, suggesting acquired IP rather than active development.